D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 102 Citations 37,652 521 World Ranking 4524 National Ranking 441

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Schizophrenia

Paolo Fusar-Poli mainly focuses on Psychosis, Psychiatry, Schizophrenia, Neuroscience and Meta-analysis. He is involved in the study of Psychosis that focuses on At risk mental state in particular. The concepts of his Psychiatry study are interwoven with issues in Systematic review and Randomized controlled trial.

His Schizophrenia research is multidisciplinary, relying on both Brain activity and meditation, Psychopathology, Disease and Functional neuroimaging. His Neuroscience research focuses on subjects like Cannabidiol, which are linked to Anxiolytic. He combines subjects such as Sample size determination and Receiver operating characteristic with his study of Meta-analysis.

His most cited work include:

  • Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. (993 citations)
  • Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk (960 citations)
  • The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review (903 citations)

What are the main themes of his work throughout his whole career to date?

Paolo Fusar-Poli focuses on Psychosis, Psychiatry, Schizophrenia, Neuroscience and Clinical psychology. His study explores the link between Psychosis and topics such as Audiology that cross with problems in Working memory. His research is interdisciplinary, bridging the disciplines of Meta-analysis and Psychiatry.

His research in Schizophrenia intersects with topics in Cohort study, Randomized controlled trial and Pediatrics. His research links Cannabidiol with Neuroscience. Paolo Fusar-Poli works mostly in the field of Clinical psychology, limiting it down to concerns involving Systematic review and, occasionally, Odds ratio.

He most often published in these fields:

  • Psychosis (77.09%)
  • Psychiatry (65.38%)
  • Schizophrenia (44.48%)

What were the highlights of his more recent work (between 2019-2021)?

  • Psychosis (77.09%)
  • Psychiatry (65.38%)
  • Clinical psychology (24.25%)

In recent papers he was focusing on the following fields of study:

His main research concerns Psychosis, Psychiatry, Clinical psychology, Meta-analysis and Mental health. His Psychosis study incorporates themes from Schizophrenia, Internal medicine, Cohort study, DSM-5 and Neuroimaging. His research integrates issues of Placebo, Cognition and Autism spectrum disorder in his study of Schizophrenia.

His Psychiatry research focuses on Cumulative incidence and how it connects with Medical diagnosis. His Clinical psychology research is multidisciplinary, relying on both Psychological intervention, Observational study, Systematic review, Disease and PsycINFO. Paolo Fusar-Poli focuses mostly in the field of Meta-analysis, narrowing it down to topics relating to Pregnancy and, in certain cases, Overweight and Relative risk.

Between 2019 and 2021, his most popular works were:

  • Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. (491 citations)
  • Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis. (92 citations)
  • Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention (55 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Psychiatry
  • Schizophrenia

His scientific interests lie mostly in Psychosis, Clinical psychology, Psychiatry, Schizophrenia and Mental health. He merges Psychosis with Crisis management in his study. His Clinical psychology research includes elements of PsycINFO, Systematic review, Prospective cohort study and Risk factor.

Paolo Fusar-Poli frequently studies issues relating to Quality of life and Psychiatry. His studies deal with areas such as Meta-analysis, Vitamin D and neurology, Cognition and Clinical significance as well as Schizophrenia. His Mental health research includes themes of Family medicine, Anxiety, Supportive psychotherapy, Public health and Pandemic.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.

Jonathan P Rogers;Edward Chesney;Dominic Oliver;Thomas A Pollak;Thomas A Pollak.
The Lancet Psychiatry (2020)

1608 Citations

Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies.

Paolo Fusar-Poli;Anna Placentino;Francesco Carletti;Paola Landi.
Journal of Psychiatry & Neuroscience (2009)

1484 Citations

Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk

Paolo Fusar-Poli;Ilaria Bonoldi;Alison R. Yung;Stefan Borgwardt.
Archives of General Psychiatry (2012)

1475 Citations

The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review

Paolo Fusar-Poli;Stefan Borgwardt;Andreas Bechdolf;Jean Addington.
JAMA Psychiatry (2013)

1442 Citations

Cognitive Functioning in Prodromal Psychosis: A Meta-analysis

Paolo Fusar-Poli;Giacomo Deste;Renata Smieskova;Stefano Barlati.
Archives of General Psychiatry (2012)

751 Citations

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Sagnik Bhattacharyya;Paul D Morrison;Paolo Fusar-Poli;Paolo Fusar-Poli;Rocio Martin-Santos.
Neuropsychopharmacology (2010)

721 Citations

Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis

Paolo Fusar-Poli;Barnaby Nelson;Lucia Valmaggia;Alison R. Yung.
Schizophrenia Bulletin (2014)

597 Citations

Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials

Paolo Fusar-Poli;Evangelos Papanastasiou;Daniel Stahl;Matteo Rocchetti.
Schizophrenia Bulletin (2015)

567 Citations

Cannabis and anxiety: a critical review of the evidence

José Alexandre Crippa;Antonio Waldo Zuardi;Rocio Martín-Santos;Sagnik Bhattacharyya.
Human Psychopharmacology-clinical and Experimental (2009)

520 Citations

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies

Paolo Fusar-Poli;R Smieskova;Matthew Kempton;B C Ho.
Neuroscience & Biobehavioral Reviews (2013)

513 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Paolo Fusar-Poli

Philip McGuire

Philip McGuire

King's College London

Publications: 200

Stefan Borgwardt

Stefan Borgwardt

University of Lübeck

Publications: 168

Patrick D. McGorry

Patrick D. McGorry

University of Melbourne

Publications: 166

Larry J. Seidman

Larry J. Seidman

Beth Israel Deaconess Medical Center

Publications: 144

Oliver D. Howes

Oliver D. Howes

King's College London

Publications: 134

Barnaby Nelson

Barnaby Nelson

University of Melbourne

Publications: 132

Alison R. Yung

Alison R. Yung

Deakin University

Publications: 129

Jim van Os

Jim van Os

University Medical Center Utrecht

Publications: 128

Stephen J. Wood

Stephen J. Wood

University of Melbourne

Publications: 111

Robin M. Murray

Robin M. Murray

King's College London

Publications: 109

Jean Addington

Jean Addington

University of Calgary

Publications: 108

Anita Riecher-Rössler

Anita Riecher-Rössler

University of Basel

Publications: 107

Daniel H. Mathalon

Daniel H. Mathalon

University of California, San Francisco

Publications: 101

Merete Nordentoft

Merete Nordentoft

University of Copenhagen

Publications: 100

Carrie E. Bearden

Carrie E. Bearden

University of California, Los Angeles

Publications: 97

Christos Pantelis

Christos Pantelis

University of Melbourne

Publications: 96

Trending Scientists

Ioannis Chatzigiannakis

Ioannis Chatzigiannakis

Sapienza University of Rome

Randall M. Feenstra

Randall M. Feenstra

Carnegie Mellon University

Peter St George-Hyslop

Peter St George-Hyslop

University of Cambridge

Sudhir Agrawal

Sudhir Agrawal

University of Massachusetts Medical School

Beatriz Guerra

Beatriz Guerra

European Food Safety Authority

Noriyuki Sato

Noriyuki Sato

Sapporo Medical University

Ahmed El Goresy

Ahmed El Goresy

University of Bayreuth

Valentin R. Troll

Valentin R. Troll

Uppsala University

Graham D. Layne

Graham D. Layne

Memorial University of Newfoundland

René Laprise

René Laprise

University of Quebec at Montreal

James F. Willott

James F. Willott

University of South Florida

Robert B. Nussenblatt

Robert B. Nussenblatt

National Institutes of Health

Jane A. McKeating

Jane A. McKeating

University of Oxford

Paul Kennedy

Paul Kennedy

Stoke Mandeville Hospital

Robert D. Cardiff

Robert D. Cardiff

University of California, Davis

Something went wrong. Please try again later.